Neuropathologic features of amnestic mild cognitive impairment

Arch Neurol. 2006 May;63(5):665-72. doi: 10.1001/archneur.63.5.665.


Background: The neuropathologic substrate of amnestic mild cognitive impairment (aMCI) is not known.

Objective: To determine the neuropathologic features of patients who died while their clinical classification was aMCI.

Design: Cohort study.

Setting: Community based.

Participants: Sixty-six individuals, including 15 who had memory impairment beyond that allowed for aging but who were not demented, were studied along with 28 clinically healthy individuals and 23 patients with probable Alzheimer disease (AD) for comparison.

Main outcome measures: Standard neuropathologic techniques and classification according to Khachaturian, Consortium to Establish a Registry for Alzheimer Disease, and National Institute on Aging-Reagan criteria were used to analyze autopsy tissue from 15 individuals who died while their clinical diagnosis was aMCI. For comparison, autopsy data on age-matched groups of clinically healthy individuals and patients with probable AD were analyzed.

Results: Most patients with aMCI did not meet the neuropathologic criteria for AD, but their pathologic findings suggest a transitional state of evolving AD. All the patients with aMCI had pathologic findings involving medial temporal lobe structures, likely accounting for their memory impairment. In addition, there were many concomitant pathologic abnormalities, including argyrophilic grain disease, hippocampal sclerosis, and vascular lesions.

Conclusions: The neuropathologic features of aMCI matched the clinical features and seemed to be intermediate between the neurofibrillary changes of aging and the pathologic features of very early AD.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / pathology
  • Amnesia / complications*
  • Amnesia / pathology*
  • Amyloid beta-Peptides / metabolism
  • Autopsy / methods
  • Case-Control Studies
  • Cognition Disorders / complications*
  • Cognition Disorders / pathology*
  • Cohort Studies
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Lewy Bodies / pathology
  • Male
  • Mental Status Schedule
  • Neurofibrillary Tangles / pathology
  • Plaque, Amyloid / pathology
  • Postmortem Changes
  • Residence Characteristics
  • tau Proteins / metabolism


  • Amyloid beta-Peptides
  • tau Proteins